# Trade Mark Journal No.2026/031 31 July 2026

## WO0000001927704 (1,5,10)

Office of origin: United States of America

Date of International Registration:6 May 2026
Date of designation in the UK: 6 May 2026

The mark consists of a circle containing a stylized trident with three partial circles above each tip, all above the stylized wording "IMMAGINA BIOTECHNOLOGY THE RIBOSOME COMPANY", a small shaded dot frames either side of "BIOTECHNOLOGY".

Protection of the mark shall give no rights to the exclusive use of the words "BIOTECHNOLOGY" and "THE RIBOSOME COMPANY"

Class 1
  Chemical substances for analyses in laboratories, other than for medical or veterinary purposes, chemical for use in industry and natural elements, namely, radiative elements for scientific purposes; nucleic acid sequencing programs other than for medical use, namely, nucleic acid sequences and chemical reagents for other than medical or veterinary purposes; chemical compositions and materials for use in science, namely, chemicals for use in science; chemical reagent mixtures in kit form comprised of chemical reagents other than for medical or veterinary use; chemical reagents other than for medical or veterinary purposes for use in the field of scientific research; chemicals for use in performing nucleic acid polymerase chain reactions other than medical and veterinary purposes; chemical diagnostic reagents for industrial purposes, namely, cellular culture environments, cellular regulation agents, amino acids, dna fragments, rna fragments, dna probes, rna probes, material for genetic cloning, tagged antibodies for laboratory use; protein in raw material form for scientific and medical research; photosensitive chemicals being chemical preparations for use in photography; activators being chemicals for use in industry and science.
Class 5
  Stem cells for medical purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for medical purposes, namely, for treating cancer; chemical preparations for pharmaceutical purposes for the treatment of renal disease; diagnostic preparations for medical purposes, namely, for diagnosing cardiovascular conditions; pharmaceutical preparations for treating cancer; clinical diagnostic reagents being diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; swabs for medical purposes; biological reagents for medical use; biotechnological preparations for medical use for treating cancer; antibodies, namely, colostral antibodies for medical purposes; regulatory proteins for medical use, namely, protein arrays for medical diagnosis purposes; enzymes for medical and veterinary purposes.
Class 10
  Screening kit, namely, apparatus for DNA and RNA testing for medical purposes; biomedical diagnostic apparatus, namely, molecular diagnostic devices for medical purposes used for nucleic acid testing, infectious disease testing, genetic testing; biomedical devices in the nature of cartridges, unfilled, for medical purposes, for loading biological samples for use in molecular diagnostic devices; testing sample collection equipment, namely, swabs for obtaining biological samples from subjects for biomedical purposes; apparatus for dna and rna testing for medical purposes; apparatus for carrying-out diagnostic tests for medical purposes, namely, apparatus for DNA and RNA testing for medical purposes; screening kits for medical purposes, namely, apparatus for DNA and RNA testing for medical purposes; probes for medical purposes; sensor apparatus for medical use in diagnosis, namely, patient monitoring sensors and alarms.

Immagina Biotechnology S.r.l.

Representative: Ali R. Latifi Tucker & Latifi, LLP, 160 East 84th Street, Suite 5E, New York NY 10028, UNITED STATES OF AMERICA